MOBILion Systems, Inc.
Exton, US · Founded 2015 · Delaware corporation · 42 employees on LinkedIn · 3 known investors
MOBILion Systems develops the MOBIE platform, a high-resolution ion mobility mass spectrometry (HRIM-MS) instrument that separates and identifies complex molecules in separation science. It serves pharmaceutical, biopharma, academic, and diagnostics labs across cell and gene therapy, therapeutic characterization, food and environmental testing, and biomarker research.
Founders & leadership
MS
MELISSA SHERMANExecutive
Board
JS
MA
MICHAEL ALBINBoard director
JL
JUDIT LOSONCZIBoard director
HD
HEINER DREISMANNBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$105.1M disclosed across 4 rounds · 2019–2021
▶$60MraisedJul 2021 · 7 investors · BiotechnologyRule 506(b)
▶$60MraisedJul 2021 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MELISSA SHERMANExecutive Officer, Director
- TAD WEEMSDirector
- JASON SMITHDirector
- HEINER DREISSMANDirector
- TODD SONEDirector
- MICHAEL ALBINDirector
- CRAIG CARRAExecutive Officer
- Offering amount
- $60M
- Amount sold
- $60M
- Proceeds to insiders
- $4M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35.1MraisedAug 2020 · 7 investors · BiotechnologyRule 506(b)
▶$35.1MraisedAug 2020 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- TODD SONEDirector
- JASON SMITHDirector
- HEINER DREISSMANDirector
- MICHAEL ALBINDirector
- TAD WEEMSDirector
- MELISSA SHERMANExecutive Officer, Director
- Offering amount
- $35.1M
- Amount sold
- $35.1M
- Minimum investment
- $250K
- Proceeds to insiders
- $1.5M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$6MraisedMay 2020 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedMay 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Melissa ShermanExecutive Officer, Director
- Heiner DreissmanDirector
- Jason SmithDirector
- Alan AubreyDirector
- Tad WeemsDirector
- Michael AlbinDirector
- Offering amount
- $6M
- Amount sold
- $6M
- Minimum investment
- $6M
- Proceeds to insiders
- $250K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$4MraisedApr 2019 · 2 investors · BiotechnologyRule 506(b)
▶$4MraisedApr 2019 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL ALBINDirector
- JUDIT LOSONCZIDirector
- HEINER DREISMANNDirector
- MELISSA SHERMANExecutive Officer, Director
- JASON SMITHDirector
- Offering amount
- $10M
- Amount sold
- $4M
- Minimum investment
- $3
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with MOBILion Systems, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does MOBILion Systems, Inc. do?
- MOBILion Systems develops the MOBIE platform, a high-resolution ion mobility mass spectrometry (HRIM-MS) instrument that separates and identifies complex molecules in separation science. It serves pharmaceutical, biopharma, academic, and diagnostics labs across cell and gene therapy, therapeutic characterization, food and environmental testing, and biomarker research.
- Who are MOBILion Systems, Inc.'s investors?
- MOBILion Systems, Inc.'s investors include Anzu Partners, iSelect Fund, Cultivation Capital.
- How much funding has MOBILion Systems, Inc. raised?
- MOBILion Systems, Inc. has disclosed $105.1M raised across 4 rounds.
- Where is MOBILion Systems, Inc. headquartered?
- MOBILion Systems, Inc. is headquartered in Exton, US.